352347 <common-name>4-methyl-2-phenyl-n-[[1,3,3-trimethyl-5-[(4-methyl-2-phenyl-4,5-dihydroimidazole-1-carbonyl)amino]cyclohexyl]methyl]-4,5-dihydroimidazole-1-carboxamide</common-name> <description>4-methyl-2-phenyl-n-[[1,3,3-trimethyl-5-[(4-methyl-2-phenyl-4,5-dihydroimidazole-1-carbonyl)amino]cyclohexyl]methyl]-4,5-dihydroimidazole-1-carboxamide has the chemical formula C32H42N6O2. With an average molecular weight of 542.70 g/mol, 4-methyl-2-phenyl-n-[[1,3,3-trimethyl-5-[(4-methyl-2-phenyl-4,5-dihydroimidazole-1-carbonyl)amino]cyclohexyl]methyl]-4,5-dihydroimidazole-1-carboxamide is a heavy molecule.</description> <cas>68426-04-0</cas> <pubchem-id>21118502</pubchem-id> <chemical-formula>C32H42N6O2</chemical-formula> <weight>542.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:37:23Z</created-at> <updated-at type="dateTime">2026-08-31T18:37:23Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1CN(C(=N1)C2=CC=CC=C2)C(=O)NCC3(CC(CC(C3)(C)C)NC(=O)N4CC(N=C4C5=CC=CC=C5)C)C</moldb-smiles> <moldb-formula>C32H42N6O2</moldb-formula> <moldb-inchi>InChI=1S/C32H42N6O2/c1-22-18-37(27(34-22)24-12-8-6-9-13-24)29(39)33-21-32(5)17-26(16-31(3,4)20-32)36-30(40)38-19-23(2)35-28(38)25-14-10-7-11-15-25/h6-15,22-23,26H,16-21H2,1-5H3,(H,33,39)(H,36,40)</moldb-inchi> <moldb-inchikey>IKJUCDPTNAAYLC-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">542.3369246</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM348240</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4-methyl-2-phenyl-n-[[1,3,3-trimethyl-5-[(4-methyl-2-phenyl-4,5-dihydroimidazole-1-carbonyl)amino]cyclohexyl]methyl]-4,5-dihydroimidazole-1-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0302636</sync-id> <structure-inchikey>IKJUCDPTNAAYLC-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>208000000000001000800100200000000000000000000086000020000000000000000000000000000000040000006014000000000000000000000000080000000088000000100000000000000000000020000001000000000000009000000000000000010000000000000000000000000000120100000000000000000000100000000048000040800000000002200080800000000100000000010000000020000000040000000000000000081000000100000000000000000100000000000010000000000000000001000020000000000000000000080100000200000000000000000000000000000040000000000400000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALAAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAICBwAoAAAAAwMGACgAAAADBAcAKAAAAAMDBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGACgA AAADBAgAKAAAAAMCBwBoAAAAAwIBBgBgAAAAAgIGACAAAAAEBgBgAAAAAgIG AGAAAAADAQYAYAAAAAICBgAgAAAABAYAYAAAAAICBgBgAAAAAQMGAGAAAAAB AwcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYAYAAAAAICBgBg AAAAAwEHACgAAAADAwYAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGAGAAAAABAwYAYAAAAAED CwABAAECAAIDAAMEIAQFKAIEBiAGB2gMBwhoDAgJaAwJCmgMCgtoDAMMIAwN KAIMDiAODwAPEAAQEQAREgASEwATFAAUFQAUFgAUFwASGAAYGSAZGigCGRsg GxwAHB0AHR4AHh8oAh8gICAhaAwhImgMIiNoDCMkaAwkJWgMHSYAECcABQEA CwZoDBUQAB8bICUgaAxCBQAAAAUBAgMEBQYHCAkKCwYGERITFBUQBRwbHx4d BiEiIyQlIBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:50:06Z</structure-indexed-at> </compound>